Related Experiment Video
Updated: Jun 3, 2026
10:35
Stereotactic Radiosurgery for Gynecologic Cancer
Published on: April 17, 2012
Roles of Goserelin in Gynecological Disorders
Xiufeng Huang1,2,3, Nihao Gu4,5,6, Linhua Qian1,2,3
1Department of Gynecology, Women's Hospital, School of Medicine, Zhejiang University, Hangzhou, People's Republic of China.
Drug Design, Development and Therapy
|June 2, 2026
Summary
Goserelin, a gonadotropin-releasing hormone (GnRH) agonist, effectively treats gynecological conditions by suppressing hormones. Its versatile applications continue to expand in both benign and malignant diseases.
Area of Science:
- Gynecology
- Endocrinology
- Pharmacology
Background:
- Goserelin is a well-established gonadotropin-releasing hormone (GnRH) agonist.
- It has a proven safety and efficacy profile with a long clinical history.
- Its mechanism involves GnRH receptor desensitization, leading to hormonal suppression.
Purpose of the Study:
- To review the established and emerging roles of goserelin in gynecological conditions.
- To highlight the clinical versatility and evidence supporting goserelin's use.
- To consolidate current understanding of goserelin's utility in benign and malignant gynecological diseases.
Main Methods:
- Literature review of goserelin's clinical applications.
- Analysis of established and emerging gynecological indications.
- Consolidation of evidence for goserelin's efficacy and safety.
Main Results:
- Goserelin is approved for endometriosis, uterine fibroids, endometrial thinning, and ovarian downregulation.
- Emerging research explores its use in adenomyosis and various female cancers.
- Goserelin demonstrates efficacy in hormone-dependent gynecological conditions by reducing estradiol and progesterone.
Conclusions:
- Goserelin is a clinically versatile GnRH agonist with expanding utility in gynecology.
- Evidence supports its use in a broad spectrum of benign and malignant gynecological conditions.
- Goserelin remains a valuable therapeutic option in contemporary gynecological practice.
Related Concept Videos
01:24Gonadal and Placental Hormones
The gonads, namely the testes in males and the ovaries in females, are pivotal in producing gonadal hormones that orchestrate the intricate processes of sexual development and reproduction.
In males, testosterone is the primary gonadal androgen. It plays a central role in the maturation of male reproductive organs — the penis and testes. Additionally, testosterone is instrumental in the development of secondary sexual characteristics — a deep voice as well as facial and pubic hair growth — and...
In males, testosterone is the primary gonadal androgen. It plays a central role in the maturation of male reproductive organs — the penis and testes. Additionally, testosterone is instrumental in the development of secondary sexual characteristics — a deep voice as well as facial and pubic hair growth — and...
01:30Hormonal Control of the Ovarian Cycle
The ovarian cycle is meticulously regulated by the hypothalamic-pituitary-gonadal axis. This cycle orchestrates the release of a mature oocyte, essential for reproduction.
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle. At puberty, GnRH secretion increases in both frequency and...
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle. At puberty, GnRH secretion increases in both frequency and...
01:24Disorders of the Female Reproductive System
The female reproductive system can be affected by several disorders, including Premenstrual Syndrome (PMS), Premenstrual Dysphoric Disorder (PMDD), endometriosis, and various forms of cancer. PMS and PMDD are cyclical conditions that cause physical and emotional distress, with symptoms that include edema, mood swings, and food cravings. PMDD is a more severe form of PMS characterized by increased symptom severity that peaks during the luteal phase and tends to improve or resolve shortly after...
01:24Small GTPases - Ras and Rho
Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
Three regulatory proteins control their activity:
01:15G Protein-coupled Receptors
G Protein-Coupled Receptors or GPCRs are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to sensory stimuli such as light, odors, hormones, cytokines, or neurotransmitters.
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
01:21G-protein Coupled Receptors
G-protein coupled receptors are ligand binding receptors that indirectly affect changes in the cell. The actual receptor is a single polypeptide that transverses the cell membrane seven times creating intracellular and extracellular loops. The extracellular loops create a ligand specific pocket which binds to neurotransmitters or hormones. The intracellular loops holds onto the G-protein.